In personalized medicine, the promotion of health and the planning of treatment of diseases are based on highly specific information, such as data on the individual's genetic makeup. By combination of genetic knowledge and new technologies, we can diagnose diseases more precisely and target treatment more accurately. For this purpose, new technologies will be introduced in the healthcare sector.
The objective is that by 2020, the operating models and funding for a genome centre, a national cancer centre, a national neurocentre, and a cooperative that coordinates the operation of biobanks will be well established in Finland. These centres will help implement the Health Sector Growth Strategy and strengthen national research, development, and innovation activities and safeguards the equality and high quality of treatment in future Finland.
Strong national coordination and joint operators are a prerequisite for the full utilisation of healthcare data reserves, biobanks’ sample collections and the new genomic data.
Read more about the Health Sector Growth Strategy